These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 23848523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Incorporation of an interferon-β neutralizing antibody assay into routine clinical practice.
    Farrell RA, Espasandin M, Lakdawala N, Creeke PI, Worthington V, Giovannoni G.
    Mult Scler; 2011 Nov; 17(11):1333-40. PubMed ID: 21685230
    [Abstract] [Full Text] [Related]

  • 4. Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
    Cludts I, Meager A, Thorpe R, Wadhwa M.
    J Immunol Methods; 2013 Sep 30; 395(1-2):37-44. PubMed ID: 23831137
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to interferon beta in patients with multiple sclerosis receiving CinnoVex, rebif, and betaferon.
    Zare N, Zarkesh-Esfahani SH, Gharagozloo M, Shaygannejad V.
    J Korean Med Sci; 2013 Dec 30; 28(12):1801-6. PubMed ID: 24339712
    [Abstract] [Full Text] [Related]

  • 6. MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients.
    Libertinova J, Meluzinova E, Matoska V, Zajac M, Kovarova I, Havrdova E, Horakova D, Tomek A, Marusic P, Bojar M.
    Brain Behav; 2017 Mar 30; 7(3):e00644. PubMed ID: 28293479
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study.
    Pachner AR, Warth JD, Pace A, Goelz S, INSIGHT investigators.
    Neurology; 2009 Nov 03; 73(18):1493-500. PubMed ID: 19884577
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies.
    Hartung HP, Kieseier B, Goodin DS, Arnason BG, Comi G, Cook S, Filippi M, Jeffery DR, Kappos L, Bogumil T, Stemper B, Sandbrink R, Nakada Y, Nakajima H, Schwenke S, Lehr S, Heubach J, Pohl C, Reischl J.
    J Neuroinflammation; 2012 Jun 15; 9():129. PubMed ID: 22703536
    [Abstract] [Full Text] [Related]

  • 19. Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta.
    Gilli F, De La Torre AL, Royce DB, Pachner AR.
    Int Immunopharmacol; 2018 Sep 15; 62():1-6. PubMed ID: 29960044
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.